Zosano Pharma
Zosano Pharma was a clinical-stage biopharmaceutical company developing transdermal microneedle systems for drug delivery. Its investigational candidates included Qtrypta (M207) for migraine and C213 for cluster headache. The company entered liquidation in 2022.
Key facts
| Legal Name | Zosano Pharma, Inc. |
|---|---|
| Company Operating Status | Closed |
| Full Address | 34790 Ardentech Court Fremont, California 94555 |
| Previous Name | ZP Holdings Inc |
| Stock Symbol | ZSANQ |
| Ticker Symbol | ZSAN |
| Wellfound ID | zosano-pharma |